Vise Technologies’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
29,159
-2,459
-8% -$134K 0.01% 702
2026
Q1
$3.01M Hold
31,618
– – 0.06% 256
2025
Q4
$3.01M Buy
31,618
+3,332
+12% +$327K 0.06% 257
2025
Q3
$2.76M Sell
28,286
-1,932
-6% -$200K 0.1% 188
2025
Q2
$3.25M Buy
+30,218
New +$3.06M 0.13% 166
2024
Q4
$1.98M Buy
22,170
+11,439
+107% +$1.01M 0.17% 134
2024
Q3
$899K Buy
10,731
+7,185
+203% +$566K 0.11% 179
2024
Q2
$273K Buy
3,546
+447
+14% +$32.7K 0.05% 332
2024
Q1
$212K Buy
+3,099
New +$199K 0.04% 353

Other funds holding BSX

Vise Technologies's BSX Position: Q2 2026 in Review

Vise Technologies reduced its Boston Scientific (BSX) stake by 7.8% in Q2 2026, selling an estimated $134K and leaving 29,159 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #702.

Vise Technologies first reported a position in BSX in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.25M in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vise Technologies held 29,159 shares of Boston Scientific worth $1.24M as of Q2 2026.
  • Vise Technologies sold 2,459 Boston Scientific shares in Q2 2026, an estimated $134K.
  • Boston Scientific made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #702 holding.
  • Vise Technologies first reported a position in Boston Scientific in Q1 2024 and has held it in 9 quarters since.
  • Vise Technologies's Boston Scientific position peaked at $3.25M in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.